Inventor · Beijing, CN

Kevin Chen

16Patents
3h-index
17Co-inventors
57Inventor score

Filing activity: Jun 3, 1998 → Sep 29, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US10273280B2 Chimeric antigen receptors (CARs), targeting hematologic malignancies, compositions and methods of use thereof Chemistry; Metallurgy 12 Active
US11173179B2 Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof Human Necessities 3 Active
US6235882A Gene encoding a putative efflux protein for solvents/antibiotics in pseudomonas mendocina Emerging Cross-Sectional Technologies 3 Expired
US6830899B1 Method for the production of para-hydroxybenzoate in Pseudomonas mendocina Chemistry; Metallurgy 2 Expired
US11278506B2 Pharmaceutical formulation Human Necessities 1 Active
US11655452B2 Chimeric antigen receptors (CARs), compositions and methods of use thereof Chemistry; Metallurgy 1 Active
US11466075B2 Yeast-based immunotherapy against clostridium difficile infection Chemistry; Metallurgy 1 Active
US6225089A Gene encoding a putative efflux protein for solvents/antibiotics in pseudomonas mendocina Emerging Cross-Sectional Technologies 1 Expired
US11820819B2 Chimeric antigen receptors (CARs), compositions and methods thereof Chemistry; Metallurgy 0 Active
US6410265B1 Gene encoding a putive efflux protein for solvents/antibiotics in Pseudomonas mendocina Emerging Cross-Sectional Technologies 0 Expired
US11905528B2 Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof Chemistry; Metallurgy 0 Active
US12370189B2 Pharmaceutical formulation Human Necessities 0 Active
US11135238B2 Methods to stabilize and reverse atherosclerotic lesions by sulfated polysaccharides Chemistry; Metallurgy 0 Active
US12384833B2 Yeast-based immunotherapy against Clostridium difficile infection Chemistry; Metallurgy 0 Active
US12275787B2 Chimeric antigen receptors (CARs), compositions and methods thereof Chemistry; Metallurgy 0 Active
US12257218B2 Pharmaceutical formulation Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.